reviewNature reviews. CancerSep 24, 2013Closed access

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

Umeå University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

650
total citations
FWCI
34.97
Percentile
100%
References
226
Citations per year

Authors

2

Topics & keywords

Keywords
  • Crizotinib
  • Anaplastic lymphoma kinase
  • Lung cancer
  • Cancer research
  • ALK inhibitor
  • Tyrosine kinase
  • Cancer
  • Receptor tyrosine kinase
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding